- Home
- Gastroenterology
- Empagliflozin in CKD: Slowing Disease Progression Beyond Glycaemic Control

19h3 min read
Medical Article
Introduction / Case Summary: A 62-year-old man with type 2 diabetes mellitus (T2DM), hypertension, and stage 3 chronic kidney disease (CKD) showed progressive decline in estimated glomerular filtration rate (eGFR) and persistent albuminuria despite renin–angiotensin system [RAS] blockade. Baseline values: eGFR 42 mL/min/1.73 m², urinary albumin-to-

Empagliflozin in CKD: Slowing Disease Progression Beyond Glycaemic Control
Similar Content

Single-incision Laparoscopy for Gastrostomy
407 Reached2 Comments1 Likes

Intestinal Obstruction and Ileocolic Fistula due to Gossypiboma
861 Reached30 Comments15 Likes

Woman with Complaint of Spontaneous Massive Rectal Prolapse
1865 Reached17 Comments9 Likes

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes

Pregnant Woman with HIV-1 Infection
747 Reached1 Likes